{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:21:41Z","timestamp":1792012901755,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Failure to take medications regularly leads to poorer health outcomes. The Pediatric Rheumatology Adherence Questionnaire (PRAQ) is an effective tool for assessing medication adherence in rheumatic patients. Therefore, we aimed to determine the factors associated with poor medication adherence among children with rheumatic diseases.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This was a cross-sectional study. Patients with rheumatic diseases who had taken at least one medication and had been followed up at our pediatric rheumatology clinic were included in the study, together with their caregivers. Patients with poor medication adherence were characterized as those who had taken less than 80% of their prescribed drugs, as determined using the pill count method. The original PRAQ was translated and validated in Thai language and was completed by caregivers and literate patients over age 13\u00a0years. Interviewing for additional problems with taking medications was conducted. We performed descriptive and logistic regression analyses.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> From 210 patients, 52.86% had juvenile idiopathic arthritis (JIA), and 46.19% had connective tissue diseases. The mean patient age was 14.10 \u00b1 4.74\u00a0years, with a median (interquartile range) disease duration of 4.33 (2.08\u20136.98)\u00a0years. PRAQ scores in the group with poor adherence were significantly higher than scores in the group with good adherence (11.00 \u00b1 3.47 vs. 9.51 \u00b1 3.16, <jats:italic>p<\/jats:italic> = 0.004). Enthesitis-related arthritis (ERA) (odds ratio [OR] 9.09, 95% confidence interval [CI] 1.25\u201366.18; <jats:italic>p<\/jats:italic> = 0.029) and polyarticular JIA (OR 6.43, 95% CI 1.30\u201331.75; <jats:italic>p<\/jats:italic> = 0.022) were associated with poor treatment adherence. Disease duration \u22655\u00a0years (OR 3.88, 95% CI 1.17\u201312.87; <jats:italic>p<\/jats:italic> = 0.027), active disease (OR 6.49, 95% CI 1.76\u201323.99; <jats:italic>p<\/jats:italic> = 0.005), PRAQ scores \u226512 (OR 6.48, 95% CI 1.76\u201323.82; <jats:italic>p<\/jats:italic> = 0.005), forgetting to take medications (OR 14.18, 95% CI 4.21\u201347.73; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), and unawareness about the importance of the medicines (OR 44.18, 95% CI 11.30\u2013172.73; <jats:italic>p<\/jats:italic> &amp;lt; 0.001) were predictors of poor drug adherence.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In the present study, poor medication adherence was found in one-fourth of children with rheumatic illnesses, particularly those with ERA, polyarticular JIA, longer disease duration, active disease, and high PRAQ scores. The most frequent reasons for inadequate medication adherence were forgetfulness and unawareness about the importance of disease control and consistency with treatment.<\/jats:p>","DOI":"10.3389\/fphar.2023.1149320","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:52:52Z","timestamp":1683262372000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with medication adherence among children with rheumatic diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Roongroj","family":"Manatpreeprem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Butsabong","family":"Lerkvaleekul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soamarat","family":"Vilaiyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.rbre.2016.05.004","article-title":"Medication adherence in patients with juvenile idiopathic arthritis","volume":"57","author":"Adriano","year":"2017","journal-title":"Rev. Bras. Reumatol. Engl. Ed."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11096-018-0756-z","article-title":"The treatment-related experiences of parents, children and young people with regular prescribed medication","volume":"41","author":"Aston","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/030802260206501004","article-title":"Views from the inside, Part 3: How and why families undertake prescribed exercise and splinting programmes and a new model of the families' experience of living with juvenile arthritis","volume":"65","author":"Britton","year":"2002","journal-title":"Br. J. Occup. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2223\/JPED.2227","article-title":"Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases","volume":"88","author":"Bugni","year":"2012","journal-title":"J. Pediatr. (Rio J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/PPA.S147420","article-title":"Barriers to treatment: Describing them from a different perspective","volume":"12","author":"Devine","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-816000-8.00001-3","article-title":"Introduction","volume-title":"Adherence and self-management in pediatric populations","author":"Driscoll","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1310\/hpj5202-124","article-title":"Pharmacists and pediatric medication adherence: Bridging the gap","volume":"52","author":"El-Rachidi","year":"2017","journal-title":"Hosp. Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3899\/jrheum.171087","article-title":"Barriers to adherence in juvenile idiopathic arthritis: A multicenter collaborative experience and preliminary results","volume":"45","author":"Favier","year":"2018","journal-title":"J. Rheumatol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-816000-8.00014-1","article-title":"Rheumatic diseases","volume-title":"Adherence and self-management in pediatric populations","author":"Favier","year":"2020"},{"key":"B13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/art.22907","article-title":"Effects of adherence to treatment on short-term outcomes in children with juvenile idiopathic arthritis","volume":"57","author":"Feldman","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Comparison of methods to assess medication adherence and classify non-adherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12969-018-0280-7","article-title":"Psychological characteristics of caregivers of pediatric patients with chronic rheumatic disease in relation to treatment adherence","volume":"16","author":"Keppeke","year":"2018","journal-title":"Pediatr. Rheumatol. Online. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: An overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1546-0096-9-35","article-title":"Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey","volume":"9","author":"Lawson","year":"2011","journal-title":"Pediatr. Rheumatol. Online. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11926-014-0410-2","article-title":"Importance of adherence in the outcome of juvenile idiopathic arthritis","volume":"16","author":"Len","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0263536","DOI":"10.1371\/journal.pone.0263536","article-title":"Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus","volume":"17","author":"Lerkvaleekul","year":"2022","journal-title":"PLoS. One."},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1542\/peds.2013-1451","article-title":"Medication adherence and health care utilization in pediatric chronic illness: A systematic review","volume":"132","author":"McGrady","year":"2013","journal-title":"Pediatrics"},{"key":"B22","first-page":"100","article-title":"Factors associated with adherence to medications for children with juvenile idiopathic arthritis at Queen Sirikit National Institute of Child Health","volume":"10","author":"Nitinantaponk","year":"2018","journal-title":"Thai. J. Pharm. Prac."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0171070","DOI":"10.1371\/journal.pone.0171070","article-title":"Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?","volume":"12","author":"Pasma","year":"2017","journal-title":"PLoS. One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00296-010-1774-x","article-title":"Adherence to methotrexate in juvenile idiopathic arthritis","volume":"32","author":"Pelajo","year":"2012","journal-title":"Rheumatol. Int."},{"key":"B25","first-page":"390","article-title":"International League of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/anr.1790020407","article-title":"Improving compliance with prednisone therapy in pediatric patients with rheumatic disease","volume":"2","author":"Pieper","year":"1989","journal-title":"Arthritis Care Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","article-title":"2019 American College of rheumatology\/arthritis foundation guideline for the treatment of juvenile idiopathic arthritis: Therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis","volume":"71","author":"Ringold","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B28","volume-title":"Adherence to long-term therapies: Evidence for action","author":"Sabat\u00e9","year":"2003"},{"key":"B29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2431-14-63","article-title":"Treatment non-adherence in pediatric long-term medical conditions: Systematic review and synthesis of qualitative studies of caregivers' views","volume":"14","author":"Santer","year":"2014","journal-title":"BMC Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12969-018-0232-2","article-title":"Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study","volume":"16","author":"Scalzi","year":"2018","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.31979\/etd.rcju-wdd2","article-title":"Data from: Identifying factors in medication non-adherence in teens diagnosed with juvenile arthritis: A pilot study","author":"Senzaki","year":"2015","journal-title":"SJSU Sch. Digit. Repos."},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1590\/1984-0462\/;2019;37;2;00015","article-title":"Early detection of poor adherence to treatment of pediatric rheumatic diseases: Pediatric Rheumatology Adherence Questionnaire - a pilot study","volume":"37","author":"Silva","year":"2019","journal-title":"Rev. Paul. Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.12968\/bjon.2004.13.19.16318","article-title":"Supporting parents in managing drugs for children with cystic fibrosis","volume":"13","author":"Slatter","year":"2004","journal-title":"Br. J. Nurs."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/rheumatology\/36.11.1218","article-title":"School attendance and juvenile chronic arthritis","volume":"36","author":"Sturge","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"B35","first-page":"1934","article-title":"The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus","volume":"31","author":"Uribe","year":"2004","journal-title":"J. Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: Consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/1756-185X.12637","article-title":"A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period","volume":"19","author":"Vilaiyuk","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care Res. Hob."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.socscimed.2005.04.034","article-title":"Pediatric adherence: Perspectives of mothers of children with HIV","volume":"61","author":"Wrubel","year":"2005","journal-title":"Soc. Sci. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1149320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:52:57Z","timestamp":1683262377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1149320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":39,"alternative-id":["10.3389\/fphar.2023.1149320"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1149320","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1149320"}}